Literature DB >> 7869519

Hypercalciuria and nephrocalcinosis in the oculocerebrorenal syndrome.

G A Sliman1, W D Winters, D W Shaw, E D Avner.   

Abstract

The oculocerebrorenal (Lowe) syndrome is an X-linked recessive disorder characterized by congenital cataracts, hypotonia, developmental delay, poor growth and renal tubular dysfunction. Although the disorder has been mapped to chromosome Xq24-26, the underlying metabolic defect remains unknown. The renal component of the Lowe syndrome comprises tubular dysfunction, that is tubular proteinuria and generalized aminoaciduria progressing to the renal Fanconi syndrome, with later glomerular disease. Clinical problems typically include polyuria, acidosis, hypophosphatemia with rickets and eventually end stage renal disease. Hypercalciuria and its sequelae (nephrocalcinosis and nephrolithiasis) have not been described as cardinal features of the untreated disorder although they reportedly complicate vitamin D and calcium therapy of rickets. We discuss 5 boys with congenital cataracts, hypotonia, developmental delay, failure to thrive and the renal Fanconi syndrome who were diagnosed with the Lowe syndrome and in whom hypercalciuria was documented at diagnosis. We conclude that hypercalciuria and its sequelae may occur commonly in patients with the Lowe syndrome as a component of tubular dysfunction or a complication of therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7869519

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease.

Authors:  Guojin Wu; Wei Zhang; Tao Na; Haiyan Jing; Hongju Wu; Ji-Bin Peng
Journal:  Am J Physiol Cell Physiol       Date:  2012-02-29       Impact factor: 4.249

Review 2.  Genetic determinants of urolithiasis.

Authors:  Carla G Monico; Dawn S Milliner
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

3.  Dent Disease with mutations in OCRL1.

Authors:  Richard R Hoopes; Antony E Shrimpton; Stephen J Knohl; Paul Hueber; Bernd Hoppe; Janos Matyus; Ari Simckes; Velibor Tasic; Burkhard Toenshoff; Sharon F Suchy; Robert L Nussbaum; Steven J Scheinman
Journal:  Am J Hum Genet       Date:  2004-12-30       Impact factor: 11.025

Review 4.  Genetic causes of hypercalciuric nephrolithiasis.

Authors:  Michael J Stechman; Nellie Y Loh; Rajesh V Thakker
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

Review 5.  Acidosis and Urinary Calcium Excretion: Insights from Genetic Disorders.

Authors:  R Todd Alexander; Emmanuelle Cordat; Régine Chambrey; Henrik Dimke; Dominique Eladari
Journal:  J Am Soc Nephrol       Date:  2016-07-28       Impact factor: 10.121

Review 6.  Inherited cerebrorenal syndromes.

Authors:  Scott J Schurman; Steven J Scheinman
Journal:  Nat Rev Nephrol       Date:  2009-09       Impact factor: 28.314

7.  Renal manifestations of Dent disease and Lowe syndrome.

Authors:  Hee Yeon Cho; Bum Hee Lee; Hyun Jin Choi; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2007-11-24       Impact factor: 3.714

8.  Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction.

Authors:  Detlef Bockenhauer; Arend Bokenkamp; William van't Hoff; Elena Levtchenko; Joana E Kist-van Holthe; Velibor Tasic; Michael Ludwig
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-14       Impact factor: 8.237

Review 9.  The oculocerebrorenal syndrome of Lowe: an update.

Authors:  Arend Bökenkamp; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2016-03-24       Impact factor: 3.714

10.  Hydrochlorothiazide reduces urinary calcium excretion in a child with Lowe syndrome.

Authors:  Lavjay Butani
Journal:  Clin Kidney J       Date:  2015-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.